<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0015756"><a href="http://purl.obolibrary.org/obo/MONDO_0015756">MONDO:0015756</a></h3>
<p><strong>Label:</strong> myeloid hemopathy</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0013794">MONDO:0013794</a> (thrombocythemia 3), <a href="http://purl.obolibrary.org/obo/MONDO_0011173">MONDO:0011173</a> (thrombocythemia 2), <a href="http://purl.obolibrary.org/obo/MONDO_0009692">MONDO:0009692</a> (primary myelofibrosis), <a href="http://purl.obolibrary.org/obo/MONDO_0019457">MONDO:0019457</a> (Therapy related acute myeloid leukemia and myelodysplastic syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0019454">MONDO:0019454</a> (refractory anemia with excess blasts), <a href="http://purl.obolibrary.org/obo/MONDO_0019111">MONDO:0019111</a> (familial thrombocytosis), <a href="http://purl.obolibrary.org/obo/MONDO_0019452">MONDO:0019452</a> (chronic myeloproliferative disease, unclassifiable), <a href="http://purl.obolibrary.org/obo/MONDO_0019453">MONDO:0019453</a> (refractory cytopenia with multilineage dysplasia), <a href="http://purl.obolibrary.org/obo/MONDO_0018881">MONDO:0018881</a> (myelodysplastic syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0015691">MONDO:0015691</a> (hypereosinophilic syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0005029">MONDO:0005029</a> (essential thrombocythemia), <a href="http://purl.obolibrary.org/obo/MONDO_0011996">MONDO:0011996</a> (chronic myelogenous leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0017834">MONDO:0017834</a> (secondary hypereosinophilic syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0011118">MONDO:0011118</a> (acute myeloid leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0017858">MONDO:0017858</a> (acute erythroid leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0015688">MONDO:0015688</a> (myeloid neoplasms associated with eosinophilia and abnormality of PDGFRA, PDGFRB or FGFR1), <a href="http://purl.obolibrary.org/obo/MONDO_0018874">MONDO:0018874</a> (acute myeloid leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0018872">MONDO:0018872</a> (acute megakaryoblastic leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0020078">MONDO:0020078</a> (acute myeloid leukemia with recurrent genetic anomaly), <a href="http://purl.obolibrary.org/obo/MONDO_0008554">MONDO:0008554</a> (thrombocythemia 1), <a href="http://purl.obolibrary.org/obo/MONDO_0020311">MONDO:0020311</a> (chronic myelomonocytic leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0020312">MONDO:0020312</a> (atypical chronic myeloid leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0019460">MONDO:0019460</a> (acute leukemia of ambiguous lineage), <a href="http://purl.obolibrary.org/obo/MONDO_0007896">MONDO:0007896</a> (acute monocytic leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0020076">MONDO:0020076</a> (myeloproliferative neoplasm), <a href="http://purl.obolibrary.org/obo/MONDO_0020077">MONDO:0020077</a> (myelodysplastic/myeloproliferative disease), <a href="http://purl.obolibrary.org/obo/MONDO_0015667">MONDO:0015667</a> (unclassified acute myeloid leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0013667">MONDO:0013667</a> (myelodysplastic syndrome),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_86839">Orphanet:86839</a>, <a href="http://purl.obolibrary.org/obo/OMIM_187950">OMIM:187950</a>, <a href="http://www.orpha.net/ORDO/Orphanet_86836">Orphanet:86836</a>, <a href="http://www.orpha.net/ORDO/Orphanet_52688">Orphanet:52688</a>, <a href="http://purl.obolibrary.org/obo/OMIM_151380">OMIM:151380</a>, <a href="http://purl.obolibrary.org/obo/OMIM_601977">OMIM:601977</a>, <a href="http://www.orpha.net/ORDO/Orphanet_86830">Orphanet:86830</a>, <a href="http://www.orpha.net/ORDO/Orphanet_86851">Orphanet:86851</a>, <a href="http://www.orpha.net/ORDO/Orphanet_3318">Orphanet:3318</a>, <a href="http://www.orpha.net/ORDO/Orphanet_519">Orphanet:519</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98836">Orphanet:98836</a>, <a href="http://www.orpha.net/ORDO/Orphanet_518">Orphanet:518</a>, <a href="http://www.orpha.net/ORDO/Orphanet_168943">Orphanet:168943</a>, <a href="http://www.orpha.net/ORDO/Orphanet_167714">Orphanet:167714</a>, <a href="http://www.orpha.net/ORDO/Orphanet_514">Orphanet:514</a>, <a href="http://www.orpha.net/ORDO/Orphanet_318">Orphanet:318</a>, <a href="http://www.orpha.net/ORDO/Orphanet_71493">Orphanet:71493</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98274">Orphanet:98274</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98275">Orphanet:98275</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98277">Orphanet:98277</a>, <a href="http://purl.obolibrary.org/obo/OMIM_300331">OMIM:300331</a>, <a href="http://purl.obolibrary.org/obo/OMIM_133180">OMIM:133180</a>, <a href="http://www.orpha.net/ORDO/Orphanet_86846">Orphanet:86846</a>, <a href="http://purl.obolibrary.org/obo/OMIM_601626">OMIM:601626</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614286">OMIM:614286</a>, <a href="http://purl.obolibrary.org/obo/OMIM_131440">OMIM:131440</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614521">OMIM:614521</a>, <a href="http://purl.obolibrary.org/obo/OMIM_254450">OMIM:254450</a>, <a href="http://www.orpha.net/ORDO/Orphanet_168956">Orphanet:168956</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98823">Orphanet:98823</a>, <a href="http://www.orpha.net/ORDO/Orphanet_824">Orphanet:824</a>, <a href="http://www.orpha.net/ORDO/Orphanet_98824">Orphanet:98824</a>, <a href="http://purl.obolibrary.org/obo/OMIM_608232">OMIM:608232</a>, <a href="http://www.orpha.net/ORDO/Orphanet_521">Orphanet:521</a>, <a href="http://www.orpha.net/ORDO/Orphanet_314962">Orphanet:314962</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0001909">HP:0001909</a> (Leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology))) 46.56%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001909">HP:0001909</a> (Leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0011121">HP:0011121</a> (Abnormality of skin morphology))) 45.59%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001909">HP:0001909</a> (Leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000225">HP:0000225</a> (Gingival bleeding))) 40.64%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001909">HP:0001909</a> (Leukemia) 39.94%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001909">HP:0001909</a> (Leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000024">HP:0000024</a> (Prostatitis))) 39.94%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001909">HP:0001909</a> (Leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000023">HP:0000023</a> (Inguinal hernia))) 39.94%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001909">HP:0001909</a> (Leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000021">HP:0000021</a> (Megacystis))) 39.94%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001909">HP:0001909</a> (Leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000019">HP:0000019</a> (Urinary hesitancy))) 39.94%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001909">HP:0001909</a> (Leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000018">HP:0000018</a> (null))) 39.94%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001909">HP:0001909</a> (Leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000017">HP:0000017</a> (Nocturia))) 39.94%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001909">HP:0001909</a> (Leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000016">HP:0000016</a> (Urinary retention))) 39.94%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001909">HP:0001909</a> (Leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000013">HP:0000013</a> (Hypoplasia of the uterus))) 39.94%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001909">HP:0001909</a> (Leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000012">HP:0000012</a> (Urinary urgency))) 39.94%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001909">HP:0001909</a> (Leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000011">HP:0000011</a> (Neurogenic bladder))) 39.94%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001909">HP:0001909</a> (Leukemia) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000004">HP:0000004</a> (null))) 39.94%</li>
</ul>
</body>
</html>
